Vasospasm, Intracranial
12
1
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)
Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Therapeutic Hypercapnia After Aneurysmal Subarachnoid Hemorrhage - Optimum Duration of Hypercapnia
Prolonged Vasospasm in Subarachnoid Hemorrhage
An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm
An Evaluation of a Non-invasive Brain Monitor
Lumenate Observational Vasospasm Interventional Trial (LOVIT)
The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage